CURI
Price
$1.60
Change
+$0.08 (+5.26%)
Updated
Nov 14, 03:15 PM (EDT)
125 days until earnings call
FSBN
Price
$2.35
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

CURI vs FSBN

Header iconCURI vs FSBN Comparison
Open Charts CURI vs FSBNBanner chart's image
CuriosityStream
Price$1.60
Change+$0.08 (+5.26%)
Volume$100
CapitalizationN/A
FrankSpeech Network
Price$2.35
Change-$0.00 (-0.00%)
Volume$6.81K
CapitalizationN/A
CURI vs FSBN Comparison Chart
Loading...
CURI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CURI vs. FSBN commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURI is a Hold and FSBN is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (CURI: $1.52 vs. FSBN: $2.35)
Brand notoriety: CURI and FSBN are both not notable
Both companies represent the Broadcasting industry
Current volume relative to the 65-day Moving Average: CURI: 92% vs. FSBN: 79%
Market capitalization -- CURI: $82.99M vs. FSBN: $90.71M
CURI [@Broadcasting] is valued at $82.99M. FSBN’s [@Broadcasting] market capitalization is $90.71M. The market cap for tickers in the [@Broadcasting] industry ranges from $18.73B to $0. The average market capitalization across the [@Broadcasting] industry is $983.04M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURI’s FA Score shows that 1 FA rating(s) are green whileFSBN’s FA Score has 1 green FA rating(s).

  • CURI’s FA Score: 1 green, 4 red.
  • FSBN’s FA Score: 1 green, 4 red.
According to our system of comparison, FSBN is a better buy in the long-term than CURI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURI’s TA Score shows that 5 TA indicator(s) are bullish.

  • CURI’s TA Score: 5 bullish, 4 bearish.

Price Growth

CURI (@Broadcasting) experienced а -42.21% price change this week, while FSBN (@Broadcasting) price change was +2.17% for the same time period.

The average weekly price growth across all stocks in the @Broadcasting industry was -5.03%. For the same industry, the average monthly price growth was -7.09%, and the average quarterly price growth was +65269.09%.

Reported Earning Dates

CURI is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Broadcasting (-5.03% weekly)

Broadcasting industry includes companies that operate facilities broadcasting radio and/or television programs. Sirius XM Holdings, Inc. (which provides satellite radio and online radio services); Fox Corporation (news and sports broadcasting on TV); and CBS Corporation (TV broadcasting) are some of the behemoths of this industry. The burgeoning digital space has been a disruption for the industry, propelling them to up the ante on their own digital presence.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FSBN($90.7M) has a higher market cap than CURI($83M). FSBN YTD gains are higher at: 2349900.000 vs. CURI (196.008). CURI has higher annual earnings (EBITDA): 5.05M vs. FSBN (175K). CURI has more cash in the bank: 39.5M vs. FSBN (721). FSBN has less debt than CURI: FSBN (287K) vs CURI (4.09M). CURI has higher revenues than FSBN: CURI (54.8M) vs FSBN (1.16M).
CURIFSBNCURI / FSBN
Capitalization83M90.7M92%
EBITDA5.05M175K2,885%
Gain YTD196.0082349900.0000%
P/E RatioN/A3.85-
Revenue54.8M1.16M4,708%
Total Cash39.5M7215,478,502%
Total Debt4.09M287K1,425%
FUNDAMENTALS RATINGS
FSBN: Fundamental Ratings
FSBN
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CURI
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
CURI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TBPH9.690.78
+8.75%
Theravance Biopharma
HD410.197.11
+1.76%
Home Depot
BGFV1.78-0.02
-1.11%
Big 5 Sporting Goods Corp
NAVI15.25-0.25
-1.61%
Navient Corp
NXT37.28-0.90
-2.36%
Nextracker

CURI and

Correlation & Price change

A.I.dvisor tells us that CURI and SALM have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CURI and SALM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURI
1D Price
Change %
CURI100%
-3.18%
SALM - CURI
23%
Poorly correlated
+8.65%
SSP - CURI
22%
Poorly correlated
-6.72%
BBGI - CURI
20%
Poorly correlated
-4.14%
CMLS - CURI
20%
Poorly correlated
-5.59%
IHRT - CURI
11%
Poorly correlated
-4.18%
More

FSBN and

Correlation & Price change

A.I.dvisor tells us that FSBN and MNIZ have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FSBN and MNIZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FSBN
1D Price
Change %
FSBN100%
-6.37%
MNIZ - FSBN
11%
Poorly correlated
N/A
NPTVF - FSBN
7%
Poorly correlated
N/A
CURI - FSBN
7%
Poorly correlated
-3.18%
SJ - FSBN
3%
Poorly correlated
-11.40%
FUBO - FSBN
-3%
Poorly correlated
+1.32%
More